Transforming pharma & biotech R&D with advanced organoid solutions
Our organoid-on-plate tactical roadmap is designed to transform pharmaceutical, biotechnological, and diagnostic applications.
By developing automated and standardized solutions, we enhance the production, sorting, positioning, maturation, and analysis of organoid technology integral to drug discovery, tissue engineering, and diagnostic procedures.
Automated microphysiological systems and organ-on-chip are developed for complex 3D models on plate and chip from design to biovalidation. The complex 3D models range from spheroids, microtissues, organoids, tumor organoids, assembloids to cuboids.
Our innovative approach integrates advanced organoid technologies with R&D processes, paving the way for accelerated drug discovery and development in the pharmaceutical and biotechnological sectors.
From accelerating drug discovery to advancing personalized medicine, organoid technology is reshaping biomedical research and therapeutic development. The following case studies highlight successful implementations of automated organoid solutions across pharmaceutical, biotechnology, and diagnostic applications—driving gains in efficiency, predictive accuracy, and translational relevance.
Together, these collaborations demonstrate CSEM’s ability to turn cutting-edge organoid innovations into scalable, industry-ready solutions that address real-world challenges.
Whether you're developing next-generation therapeutics, advancing personalized medicine, or scaling drug discovery processes, our team of experts is ready to collaborate with you, from initial concept development to full-scale implementation. Contact us today to discuss your needs.